UBS Group’s Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 MACC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-906
Closed 11917
2022
Q3
$0 Hold
906
﹤0.01% 11623
2022
Q2
$0 Buy
906
+400
+79% +$62 ﹤0.01% 11561
2022
Q1
$0 Sell
506
-1,454
-74% -$483 ﹤0.01% 11421
2021
Q4
$1K Buy
+1,960
New +$1.14K ﹤0.01% 10175

Other funds holding MACC.WS

UBS Group's MACC.WS Position: Q4 2022 in Review

UBS Group sold out of Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (MACC.WS) in Q4 2022, closing a stake of 906 shares.

UBS Group first reported a position in MACC.WS in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 1 fund tracked by Wall St. Rank holds MACC.WS as of Q4 2022.

  • UBS Group reported no remaining Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 906 Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2022.
  • UBS Group first reported a position in Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 4 quarters.
  • UBS Group's Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $1K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.